Skip to content

The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study

The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03004755
Acronym
PEACE
Enrollment
500
Registered
2016-12-29
Start date
2014-03-31
Completion date
2024-09-30
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Solid Tumor, Adult

Brief summary

Historically, cancer research has been limited by sample acquisition in late stage disease, often restricted to single sites of disease with limited parallel clinical data collection in terms of prior therapy exposure. The PEACE study is intended to facilitate tissue donation from multiple tumour sites in the post-mortem setting and enable future research using samples collected at post-mortem within different disciplines related to cancer research.

Interventions

OTHERTissue Harvest

Sponsors

Cancer Research UK
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Confirmed diagnosis of any form of solid malignancy with metastatic disease (where the site of origin is known or unknown), with the exception of primary brain tumour in which there may not be evidence of metastatic disease * Oral and written informed consent from patient to enter the study and to undergo tumour harvesting after death or informed consent from a person in a qualifying relationship after the patient has died.

Exclusion criteria

* Medical or psychiatric condition that would preclude informed consent * History of intravenous drug abuse within the last 5 years * History of known high-risk infections (e.g. HIV/AIDS-positive, hepatitis B/C, tuberculosis and Creutzfeldt-Jacob disease).

Design outcomes

Primary

MeasureTime frame
Perform 500 post mortems5 years

Countries

United Kingdom

Contacts

Primary ContactAbby Sharp
ctc.peace@ucl.ac.uk02076799688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026